InvestSMART

Botanix Pharmaceuticals Ltd (ASX: BOT) - Announcements

Current share price for BOT : $0.009 0.001 (10%)+

ASX company news and announcements for Botanix Pharmaceuticals Ltd (BOT) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Botanix Pharmaceuticals Ltd (BOT) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Botanix Pharmaceuticals Ltd (BOT), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Botanix Pharmaceuticals Ltd (BOT)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$25 Notice of Annual General Meeting/Proxy Form 21 Oct 2020 6:33PM $0.094 $0.009 fallen by 90.43%
$25 Appendix 4C - Quarterly 13 Oct 2020 9:45AM $0.100 $0.009 fallen by 91%
$25 Response to ASX Price Query 29 Sep 2020 12:47PM $0.105 $0.009 fallen by 91.43%
$25 New Antimicrobial Data and Conference Presentation 8 Sep 2020 9:06AM $0.054 $0.009 fallen by 83.33%
$25 Annual Report to Shareholders with Revised Top 20 8 Sep 2020 9:01AM $0.054 $0.009 fallen by 83.33%
$25 Appendix 4G 31 Aug 2020 5:42PM $0.048 $0.009 fallen by 81.25%
$25 Appendix 4E and Annual Report to Shareholders 31 Aug 2020 5:36PM $0.048 $0.009 fallen by 81.25%
$25 BTX 1801 Phase 2a Antimicrobial Study Underway 12 Aug 2020 8:43AM $0.055 $0.009 fallen by 83.64%
$25 Appendix 4C - Quarterly 30 Jul 2020 9:18AM $0.051 $0.009 fallen by 82.35%
$25 Response to ASX Aware Query 22 Jul 2020 11:12AM $0.050 $0.009 fallen by 82%
$25 BTX 1503 End of Phase 2 Milestone with FDA 17 Jul 2020 8:57AM $0.054 $0.009 fallen by 83.33%
$25 Change of Director's Interest Notice * 4 1 Jul 2020 8:17AM $0.039 $0.009 fallen by 76.92%
$25 Appendix 3G 1 Jul 2020 8:17AM $0.039 $0.009 fallen by 76.92%
$25 Amended Constitution 24 Jun 2020 2:28PM $0.041 $0.009 fallen by 78.05%
$25 Results of Meeting 24 Jun 2020 2:07PM $0.041 $0.009 fallen by 78.05%
$25 Botanix Provides Update on Development Activities 24 Jun 2020 9:40AM $0.043 $0.009 fallen by 79.07%
$25 Letter to Shareholders - General Meeting 22 May 2020 8:48AM $0.043 $0.009 fallen by 79.07%
$25 Notice of General Meeting/Proxy Form 22 May 2020 8:46AM $0.043 $0.009 fallen by 79.07%
$25 Change of Director's Interest Notice MT 11 May 2020 8:17AM $0.045 $0.009 fallen by 80%
$25 Appendix 4C - Quarterly 30 Apr 2020 9:21AM $0.045 $0.009 fallen by 80%
$25 FDA Grants BTX 1801 QIDP Designation Status 24 Apr 2020 9:28AM $0.034 $0.009 fallen by 73.53%
$25 Proposed issue of Securities - BOT 16 Apr 2020 12:49PM $0.036 $0.009 fallen by 75%
$25 Botanix Provides Update on Development Activities Amended 16 Apr 2020 9:54AM $0.039 $0.009 fallen by 76.92%
$25 Botanix Provides Update on Development Activities 16 Apr 2020 9:30AM $0.039 $0.009 fallen by 76.92%
$25 Botanix Announces Top Line BTX 1204 Atopic Dermatitis Data 25 Mar 2020 9:36AM $0.067 $0.009 fallen by 86.57%

451 - 475 of 726 results

Page 19 of 30

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.